Clinical Trials
14 trialsNCT06815406 2026-05-06
ESD vs EMR
Azienda USL Reggio Emilia - IRCCS
Phase NA Recruiting
NCT03641313 2026-04-13
Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04919824 2026-03-24
Monopolar Current Cutting Knife vs Bipolar RFA Knife
Baylor College of Medicine
Phase NA Active not recruiting
NCT06134687 2026-03-24
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
Baylor College of Medicine
Phase NA Recruiting
NCT06159634 2026-03-24
Traction vs. No Traction in Colonic ESD
Baylor College of Medicine
Phase NA Recruiting
NCT05078866 2026-03-03
Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients
National Cancer Institute (NCI)
Phase 1/2 Active not recruiting
NCT07401303 2026-02-27
Full-time RDI for ESD: Impact on Major Adverse Events and Procedure Time
Xijing Hospital of Digestive Diseases
Phase NA Not yet recruiting
NCT07411118 2026-02-13
RCT of EFTR Versus STER for GIST Treatment
Chinese University of Hong Kong
Phase NA Recruiting
NCT07161479 2026-02-06
Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)
Samsung Medical Center
Phase NA Recruiting
NCT07373015 2026-01-28
Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase NA Not yet recruiting
NCT07317609 2026-01-05
Endosurgery-02
Shanghai Zhongshan Hospital
Phase 1 Recruiting
NCT04929392 2025-09-04
Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer
City of Hope Medical Center
Phase 2 Active not recruiting
NCT07041229 2025-06-27
ESDEMR
Pirogov Russian National Research Medical University
Phase NA Enrolling by invitation
NCT06780787 2025-06-26
FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
City of Hope Medical Center
Phase 2 Recruiting